Maya Schumer

Maya Schumer
  • Doctor of Philosophy
  • Postdoctoral Fellow at McLean Hospital

About

10
Publications
3,779
Reads
How we measure 'reads'
A 'read' is counted each time someone views a publication summary (such as the title, abstract, and list of authors), clicks on a figure, or views or downloads the full-text. Learn more
392
Citations
Introduction
Postdoctoral research fellow, McLean Hospital Translational Neuroscience in Psychiatry T32 Program, Harvard Medical School. Interests: bipolar disorder, mania/hypomania, mixed episodes, emotion-related impulsivity, neuroimaging, meta-analysis, connectomics, neural networks, improving psychometrics.
Current institution
McLean Hospital
Current position
  • Postdoctoral Fellow
Additional affiliations
September 2018 - December 2023
University of Pittsburgh
Position
  • Graduate Student Researcher
January 2013 - May 2017
Carnegie Mellon University
Position
  • Undergraduate Research Assistant
May 2013 - August 2014
Yale University
Position
  • Research Assistant
Education
September 2018 - December 2023
University of Pittsburgh
Field of study
  • Neuroscience
August 2012 - May 2016
Carnegie Mellon University
Field of study
  • Psychology

Publications

Publications (10)
Article
Full-text available
Introduction. No studies systematically examined sex differences in neural mechanisms underlying depression and mania/hypomania risk. Method. 80 females and 35 males,n=115(age21.6+/-1.90) were scanned using 3TfMRI during an implicit emotional-faces task. We examined neural activation to all emotional faces versus baseline, using an anatomical reg...
Article
Full-text available
Importance Mania/hypomania is the pathognomonic feature of bipolar disorder (BD). Established, reliable neural markers denoting mania/hypomania risk to help with early risk detection and diagnosis and guide the targeting of pathophysiologically informed interventions are lacking. Objective To identify patterns of neural responses associated with l...
Article
Full-text available
Background: Examining neural patterns associated with mania/hypomania and depression can elucidate objective risk markers of Bipolar Disorder. We aimed to identify replicable neural markers relating to current and predicting future hypo/mania and depression. Methods: Three independent samples of young adults, some experiencing psychological distre...
Article
Full-text available
Background Over the past few decades, neuroimaging research in Bipolar Disorder (BD) has identified neural differences underlying cognitive and emotional processing. However, substantial clinical and methodological heterogeneity present across neuroimaging experiments potentially hinders the identification of consistent neural biomarkers of BD. Thi...
Poster
Full-text available
Background: Negative and positive urgency (NU/PU), impulsive response tendencies to negative or positive affect, respectively, are transdiagnostic risk factors for BD. The present study assessed relationships between urgency-related neural activity during implicit facial emotion-processing and hypo/mania. Methods: A transdiagnostic cohort n=109 ad...
Poster
Full-text available
Bipolar disorder (BD) is a debilitating condition manifested during late adolescence through early adulthood and marked by difficulty regulating emotions and emotion-triggered impulsivity, which is prevalent during hypo/manic and mixed episodes and persists during inter-episode periods. Alterations to medial-lateral prefrontal cortical and subcorti...
Article
Full-text available
Objective: Over the last 10 years, there has been a dramatic increase in published randomized controlled trials (RCTs) of brief mindfulness training (from single-session inductions to multisession interventions lasting up to 2 weeks), with some preliminary indications that these training programs may improve mental health outcomes, such as negativ...
Article
Full-text available
Skin picking disorder (SPD) is a newly recognized psychiatric disorder in Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. A systematic review was conducted to assess the efficacy of pharmacological and behavioral interventions for SPD. Electronic databases were searched for randomized controlled trials (RCTs) or uncontrolled t...
Article
Full-text available
To examine long-term outcome in children with trichotillomania. We conducted follow-up clinical assessments an average of 2.8 ± 0.8 years after baseline evaluation in 30 of 39 children who previously participated in a randomized, double-blind, placebo-controlled trial of N-acetylcysteine (NAC) for pediatric trichotillomania. Our primary outcome was...

Network

Cited By